APA (7th ed.) Citation

Cooper, C., Shafran, S., Greenbloom, S., Enns, R., Farley, J., Hilzenrat, N., . . . Neuman, M. Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy. Wiley.

Chicago Style (17th ed.) Citation

Cooper, Curtis, et al. Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy. Wiley.

MLA (9th ed.) Citation

Cooper, Curtis, et al. Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy. Wiley.